Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/5499| Title: | Citalopram-induced photopigmentation | Authors: | I°nalöz, H.S. Kirtak, N. Herken, H. Özgöztaşi, O. Aynacıoğlu, Ahmet Şükrü |
Keywords: | Adverse event Citalopram Photopigmentation amitriptyline citalopram cyclophosphamide cytochrome P450 3A4 diazepam mephenytoin moclobemide omeprazole proguanil serotonin uptake inhibitor adult article case report clinical feature depression drug induced disease drug metabolism female genetic polymorphism human hyperpigmentation skin manifestation treatment outcome Depression Diagnosis, Differential Face Female Forearm Humans Hyperpigmentation Middle Aged Neck Photosensitivity Disorders Serotonin Uptake Inhibitors |
Abstract: | Citalopram is one of the newer and most potent selective serotonin re-uptake inhibitor (SSRI) drugs. It has a well-established antidepressive action with a favorable adverse event profile. We present a fifty-year-old woman with diffuse photopigmentation who had been diagnosed as suffering from depression. The patient was given citalopram (40 mg/day) for her psychiatric condition and diffuse photopigmentation was noted thereafter. To our knowledge, such an adverse event has not been reported previously. | URI: | https://hdl.handle.net/11499/5499 https://doi.org/10.1111/j.1346-8138.2001.tb00070.x |
ISSN: | 0385-2407 |
| Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
SCOPUSTM
Citations
16
checked on Jun 29, 2024
WEB OF SCIENCETM
Citations
9
checked on Jul 10, 2024
Page view(s)
30
checked on May 27, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.